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CHAPTER I 
INTRODUCTION 
A large number of antiviral compounds are currently being studied 
for possible use against viral infections of humans and animals. Very 
little is known about the effects of antiviral compounds on viral 
infections of plants. 
Plant virus chemotherapeutants are needed as an alternative to the 
preventative means of plant virus control currently used to avoid crop 
losses. Ideally, a viral chemotherapeutant would selectively inhibit 
the viral infection process without having toxic effects on the host 
cell metabolism. The compound would also have to move systemically 
throughout the plant while retaining its activity for a reasonable period 
of time to be effective. 
Antiviral compounds inhibit virus infectivity by affecting differ¬ 
ent stages of the viral infection process. Therefore, plants were 
treated with the different compounds at various times before, during, 
and after inoculation, so that their inhibitory effects would be more 
likely to be expressed. 
To best observe the effects of each antiviral compound on systemic 
and hypersensitive virus infection, it was necessary to work with a 
virus-host system in which systemic symptom development and the hyper¬ 
sensitive response could be easily observed. Such a system is provided 
by the cowpea chlorotic mottle virus (CCMV) which causes systemic 
infection in cowpea plants, Vigna unquiculata, variety "California 
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Blackeye," and hypersensitive response on soybean plants. Glycine max, 
variety "Harasoy." In addition, purified CCMV possesses good antigenic 
properties thereby making it possible to determine the effects of cer¬ 
tain antivirval compounds on the presence of CCMV antigen by immunolog¬ 
ical techniques. 
This study was undertaken to determine the effects of certain 
antiviral compounds on the presence and infectivity of CCMV in hosts 
known to exhibit systemic symptoms or the hypersensitive response, and 
thus to gain information on the possibilities for use of such compounds 
as a means of control against plant virus infections. 
CHAPTER II 
LITERATURE REVIEW 
Crop losses due to plant virus diseases generally occur in three 
situations: 1) where perennial crops develop viral symptoms after much 
time and land have been invested; 2) where annual seed crops become in¬ 
fected due to cultural or environmental conditions which favor virus 
infection; and 3) where mild but widespread infections of vegetatively 
propagated plants occur leading to small losses every year (Matthews, 
1970). Currently, only evasive control measures are available for the 
prevention of crop losses due to plant virus diseases. These measures 
include removal of virus-infected sources, control of vectors, use of 
virus-free seed and vegetative stocks, modifications of cultivation 
procedures, and ideally, use of resistant crop varieties (Agrios, 1978). 
So far no antivrial compounds have been found which would directly 
protect or cure a crop from virus infection. However, certain anti¬ 
viral compounds are known to inhibit virus infections in human, animal, 
and plant hosts (Maugh, 1976). Any one of these compounds may have po¬ 
tential for use in the prevention or cure of virus infections in plant 
crops. 
2-Thiouracil is a pyrimidine nucleoside analog which has been 
shown to have several different effects on virus infectivity. According 
to Steele and Black (1967), 2-thiouracil inhibits the absorption of 
poliovirus onto rhesus kidney cells by inactivating functional capsid 
sulfhydryl groups. When 2-thiouracil (10 ^) was added to poliovirus- 
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infected rhesus kidney monolayers, virus titre (PFU/ml) was less than 
10% of the titre of the control cultures containing no 2-thiouracil. 
Multiplication of tobacco mosaic virus (TMV), potato virus X (PVX), 
potato virus Y (PVY), and henbane mosaic virus was reduced in leaves 
of tobacco, Nicotiana tabacum, variety "White Burley," floated in 2- 
oc 
thiouracil(Bawden and Kassanis, 1954). S-labelled 2-thiouracil was 
incorporated into both host and viral RNA of TMV infected tobacco leaves. 
35 32 
The S-labelled 2-thiouracil suppressed the incorporation of P into 
viral RNA with little effect on ^^P incorporation into host RNA (Ralph, 
et al., 1 965). Therefore, it was thought that 2-thiouracil may de¬ 
crease TMV infectivity by incorporating itself into viral RNA, thereby 
interfering with virus replication(Kado and Agrawal, 1972). 
Contrary to these findings, Dawson and Kuhn (1972) observed an 
enhancement of cowpea chlorotic mottle virus (CCMV) infectivity by 
2-thiouracil. Sizes of local lesions on soybean plants. Glycine max, 
variety "Bragg," increased up to 13 times after primary leaves were 
inoculated and floated in a solution of 2-thiouracil (0.005 M). Sap 
infectivity and P incorporation into viral RNA also increased when 
primary leaves of cowpea plants, Vigna unguiculata, variety "Early 
Ramshorn," were sprayed daily with 2-thiouracil. 
Addition of uracil counteracts both the inhibitory effect of 
2-thiouracil on TMV multiplication (Commoner and Mercer, 1951) and the 
enhancement effect of 2-thiouracil on CCMV multiplication (Kuhn, 1971). 
> 
Plants sprayed with 2-thiouracil exhibit symptoms of toxicity such as 
leaf yellowing, curling, and growth inhibition (Matthews, 1970). 
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Addition of uracil had no effect upon alleviation of these toxic symp¬ 
toms (Bawden and Kassanis, 1 954) . Due to the toxic nature of 2-thiouracil, 
its use in the control of virus diseases has been avoided. 
Ribavirin (1-B-D-ribofuranosyl-l,2,4-triazole-3-carboxamide) is a 
nucleoside analog active against a variety of RNA and DNA viruses 
(DeClercq and Luczak, 1975; Maugh, 1976). The multiplication of several 
plant viruses is also known to be inhibited by ribavirin. Lerch (1977) 
reported that the multiplication of PVX in 4-week-old tobacco plants, 
Nicotiana tabacun, variety "Xanthi NC," was inhibited when roots were 
placed in a nutrient solution containing ribavirin (5 ug/ml). Inhibi¬ 
tion was measured by performing infectivity assays in which sap from 
PVX-infected tobacco leaves was inoculated onto detached leaves of 
Gomphrena qlobosa. Inhibition ranged from 23 to 78%, increasing in 
upper tobacco leaves as the distance from the lowest inoculated leaves 
increased. Inoculated tobacco plants treated with ribavirin remained 
symptomless and grew more vigorously than the control plants. 
A 40% reduction in the development of systemic symptoms was re¬ 
ported when tomato plants, Lycopersicon esculentum, were sprayed with 
ribavirin (500 mg/1) immediately after inoculation with tomato white 
necrosis virus (deFazio, et al., 1978). Virus replication, as mea¬ 
sured by infectivity assays on Chenopodium amaranticolor, was reduced 
by 89% in inoculated, ribavirin-treated plants. 
Multiplication of apple chlorotic leafspot virus in Chenopodium 
qtiinoa was completedly inhibited when ribavirin was applied between two 
days before and eight hours after inoculation (Hansen, 1979). 
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Infectivity was measured by inoculating sap from ribavirin-treated 
quinoa onto fresh quinoa. Applications of ribavirin (250 ppm) by 
leaf spray, soil drench, and brief sand culture were equally effective. 
Concentrations of ribavirin in excess of 500 ppm were phytotoxic, 
causing marginal waviness and twisting of young leaves. 
Shepard (1977) found that when calli derived from PVX-infected 
protoplasts of tobacco, Nicotiana tabacum variety "Xanthi NCwere 
exposed to ribavirin (10 mg/1) in a medium that promoted the onset of 
shoot morphogenesis, the regenerated tobacco plants showed an almost 
complete absence of PVX infection. Exposure of calli to ribavirin 
concentrations of 100 mg/1 resulted in morphological abnormalities 
including leaf narrowing and underdevelopment and a weakening of stem 
and horizontal growth. 
The mechanisms of action of ribavirin was investigated by 
Streeter, et al. (1978). Ribavirin is converted to its 5'-phosphate 
derivative within the host cell. It then becomes a potent competitive 
inhibitor of inosinate dehydrogenase which is involved in the conver¬ 
sion of inosinate to xanthylate, the immediate precursor of guanylate 
and guanosine 5'-monophosphate. This inhibition directly interferes 
with the synthesis of viral RNA or DNA. The use of ribavirin as a 
chemotherapeutant has so far been limited due to its toxic effects 
which include teratogenicity when pregnant mammals are exposed to it 
(Oxford, 1979; Maugh, 1976). 
Amantadine (1-adamantanamine hydrochloride), a tricyclic amine, is 
the only compound currently used in the prevention of viral infections 
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of the respiratory tract caused by influenza A virus (Whitley and 
Alford, 1978). Amantadine appears to interfere with a virus-cell mem¬ 
brane interaction such as penetration, uncoating, or release (Hermans, 
1977; Maugh, 1979). Kato and Eggers (1969) observed an inhibition of 
the uncoating of fowl plaque virus in chick embryo cell cultures when 
amantadine (25 ug/ml) was present 1 hour before or at the time of 
inoculation. Inhibition was characterized by a delay in the 
hemagglutination of chicken red blood cells and appearance of infective 
virus (PFU/ml) and a decrease in virus yield by 80 to 90%. 
Oxford (1979) observed that amantadine (50-100 ug/ml) had no 
effect on the absorption, penetration, uncoating, or RNA transcripase 
activity of the amantadine-sensitive influenza A virus. Instead, de¬ 
creases in polypeptide synthesis were seen using polyacrylamide gel 
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electrophoresis with S-methionine labelled polypeptides. Influenza 
A recombinants derived from resistant and suceptible parents showed 
that gene 7, which codes for the virion matrix protein, also carries 
the property of amantadine resistance. Matrix protein has been shown 
to affect late uncoating and the subsequent transcription of influenza 
A virus RNA necessary for cell infection. Therefore, amantadine may 
inhibit late uncoating (or some unknown event accompanying this) 
through its effects on matrix protein. 
The molecular basis for the mechanism of action of amantadine is 
still unknown (Oxford, 1979; Prusoff and Ward, 1976). Amantadine has 
not yet been tested for its effects on plant viruses. 
Methisazone (N-methylisatin-B-thiosemicarbazone) is a potent 
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inhibitor of the pox viruses (Maugh, 1976; Whitley and Alford, 1978; 
Hermans, 1977). However, the virtual eradication of smallpox has 
eliminated the need for methisazone. Methisazone is thought to inhibit 
an intracellular event necessary for virus replication (Prusoff and Ward, 
1976). Woodson and Jolik (1965) observed a reduction in the yield (PFU/ 
ml) of vaccinia virus grown on HeLa cell cultures in the presence of 
methisazone (3.3 ug/ml). Methisazone appears to reduce the amount of 
"late" viral messenger RNA (present from 3 hours after infection on) 
thereby resulting in a reduction of 80 to 90% in the synthesis of 
viral protein and mature viral progeny (Woodson and Jolik, 1965; 
Whitley and Alford, 1978). It has been speculated that methisazone may 
also inhibit viral replication by inhibiting the RNA-dependent-RNA 
polymerase necessary for the replication of RNA viruses (Oxford, 1979). 
The RNA-dependent-RNA polymerase of influenza virus may be a zinc- 
activated or zinc metallo-enzyme (Oxford and Perrin, 1974). Certain 
thiosemicarbazones are chelators of heavy metal ions and have been 
shown to inhibit RNA-dependent-RNA polymerases (Gingras, ^ cH., 1962). 
The precise mechanism of action of methisazone is still unknown 
(Whitley and Alford, 1978) and it has yet to be tested for its effects 
on plant viruses. 
Many benzimidazole compounds are known to inhibit virus multipli¬ 
cation (Matthews and Smith, 1955). Tamm and Eggers (1963) reported 
that 2-hydroxybenzyl-benzimidazole selectively inhibits the RNA poly- 
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merases of certain RNA animal viruses. Methyl benzimidazol-2yl- 
carbamate (MBC) is the fungitoxic principle of benomyl, a systemic 
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fungicide widely used in agriculture (Clemons and Sisler, 1969). MBC 
(2 grams per plant) was shown to suppress symptom expression of TMV in 
tobacco plants, Nicotiana tabacum variety "White Burley," and beet 
western yellows virus in lettuce, variety "Cobham Green" (Tomlinson, 
^ aj^., 1976). MBC may affect the host metabolism by preventing the 
degeneration and loss of chlorophyll which is commonly caused by TMV 
infection (Waygood, 1965). 
Fraser and Whenham (1978) observed that TTIV multiplication in 
tobacco plants, Nicotiana tabacum, varieties "White Burley" and Samsun," 
was inhibited when MBC (0.5 grams per plant) was applied as a solution 
to the roots, MBC reduced the accumulation of TMV RNA (ug TMV RNA/ 
gram fresh weight) in upper, systemically infected leaves by 9S% of 
that of the control plants, as seen by absorbance of purified extracts 
at 265 nm. MBC was shown to decrease TMV infectivity and eliminate the 
inhibition of leaf growth resulting from TMV infection. The inhibi¬ 
tion of TMV infectivity and stimulation of leaf growth caused by cyto- 
kinins (Fletcher, ^ aj_., 1968) suggests that MBC may indirectly sup¬ 
press TMV RNA accumulation, infectivity, and symptom expression by its 
known cytokinin activity (Thomas, 1974). MBC is known to be system¬ 
ically translocated throughout the plant and is stable after absorption 
at concentrations which are nontoxic thereby making it a potentially 
useful plant virus chemotherapeutant. 
Huang, it ail. (1966) reported that formycin, a base analog of 
adenosine, caused an inhibition of TMV multiplication and symptom 
development without toxicity to the host plants, Nicotiana tabacum 
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variety "Bright Yellow," and Phaseolus vulgaris variety "Pinto." Leaf 
disks of IN. tabacum variety "Bright Yellow," inoculated with TMV and 
floated on a medium containing formycin (100 ppm), exhibited a complete 
absence of systemic symptoms and an 80% inhibition of TMV multiplica¬ 
tion. Complete inhibition of local lesion formation was observed on 
£. vulgaris variety "Pinto, " when formycin (100 ppm) was sprayed 
within 12 hours before and 12 hours after TMV inoculation. 
Wawrosh and Sarkar (1974) observed an inhibition of TMV biosyn¬ 
thesis in tobacco plants, Nicotiana tabacum variety "Samsun," by formy¬ 
cin (50 ug/ml). Although, specific infectivity of TMV and TMV RNA were 
reduced in the presence of formycin, no incorporation of formycin into 
TMV or host RNA could be detected. The mechanism of action by which 
formycin inhibits TMV biosynthesis is still unknown. 
Several methods are commonly used for the application of antiviral 
compounds onto plant tissue. Floating leaves or leaf disks on a solu¬ 
tion containing the compound has the advantage of uniformly exposing 
the leaf tissue to a precise amount of the compound (Huang, et al., 
1966; Franki, 1962; Kuhn, 1971). However, this method does not permit 
observations on the effects of a compound on plant growth, virus multi¬ 
plication, and the development of systemic symptoms over a long period 
of time. In addition, leaves removed from a host plant exhibit meta¬ 
bolic changes which may influence virus multiplication and response to 
the antiviral compound. 
Leaf sprays (Dawson and Kuhn, 1972; Bawden and Kassanis, 1954) 
and soil drench (Fraser and Whenham, 1978; Hansen, 1979) are two 
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methods of application which are useful for screening tests in addition 
to having potential for practical use. Both methods permit the assess¬ 
ment of the effects of a compound on plant growth, virus multiplication, 
and the development of systemic symptoms throughout the life of the 
plant. Leaf sprays have an additional advantage of requiring less com¬ 
pound than soil drench when small plants or small numbers of plants are 
used. 
Cowpea chlorotic mottle virus (CCMV) was discovered by Kuhn in 1964. 
Since then, its structure and activity have been studied extensively. 
CCMV is an icosohedral RNA virus with a particle diameter of approxi¬ 
mately 25 nm and a molecular weight of 4.6 x 10^ daltons (Maramorosch, 
1977). The virus primarily infects legumes and is transmitted by inocu¬ 
lation with infected sap onto healthy host plants. Symptoms include the 
development of a bright yellow mottle in systemically infected cowpea 
plants (Vigna sp.) approximately two weeks after inoculation and the 
formation of dark brown local lesions on the hypersensitive host soybean. 
Glycine max, from 24 to 48 hours after inoculation. 
Purified CCMV nucleoprotein can be obtained in relatively high 
concentrations of approximately 0.4 mg of virus per gram of infected 
cowpea leaf tissue (Verduin, 1978). CCMV is most stable at a pH of 4.7. 
Therefore, CCMV purification is usually carried out in pH 4.7 acetate 
buffer by the use of chloroform-butanol extraction and differential 
ultracentrifugation (Bancroft, 1971). 
The hypersensitive response of local lesion formation on soybean 
provides a useful system for assaying the viral infectivity of plant sap 
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from infected hosts. In addition, CCMV is a good antigen (Maramorosch, 
1977), making it possible to use immunological assays for the detection 
of viral antigen. Immunofluorescence was used to detect the presence 
of CCMV in the cytoplasm of protoplasts isolated from tobacco plants, 
Nicotiana tabacum variety "White Burley" (Motoyoshi, et al., 1973). 
The enzyme-linked immunosorbent assay (ELISA) has been recently 
used for the highly sensitive detection of plant viruses. The use of 
ELISA avoids many of the limitations previously imposed by the use of 
serological techniques and infectivity assays (Clark and Adams, 1977). 
ELISA enables results to be obtained quickly and quantitatively when a 
colorimeter is used for the spectrophotometric detection of hydrolyzed 
substrate. Low virus concentrations can be detected and virus inacti¬ 
vators commonly present in plant extracts do not affect the detection 
of viral antigen by ELISA. ELISA was found to be 100 times more sensi¬ 
tive than the infectivity assay for detecting maize dwarf mosaic virus 
in extracts of infected maize leaves (Sum, ^, 1979). ELISA was 
found to be the only reliable method for the year round detection of 
chrysanthemum B virus in Chrysanthemum indicum, when compared with 
other plant virus assays (Koenig, ^ ll-, 1979). 
Since ELISA does not indicate the infectivity of the virus parti¬ 
cles, it is necessary to use both the infectivity assay and ELISA to 
provide a system for determining infectivity and concentration of the 
virus. Both of these methods have been useful for studying the effects 
of antivrial compounds on CCMV. 
CHAPTER III 
MATERIALS AND METHODS 
The Plants 
Cowpea (Viqna unguiculata, variety "California Blackeye") and soy¬ 
bean (Glycine max, variety "Harasoy") plants were grown in the green¬ 
house in sterilized soil consisting of a 1:1:1 mixture of soil, sand 
and peat moss. A solution of soluble fertilizer (16-32-16) was applied 
to the soil once a week. Plants were watered daily by direct applica¬ 
tion of water to the soil. 
When the primary leaves were fully expanded (9-11 days after plant¬ 
ing), the plants were inoculated with the appropriate dilution of virus- 
infected cowpea sap. The plants and their response to various treat¬ 
ments were then observed and recorded. 
In each experiment, one flat of plants was used for each treatment. 
Although 12 seeds per flat were planted, the 8 most uniform plants in 
each flat were selected for treatment. Four replications of each treat¬ 
ment were performed. 
The Virus 
Maintenance. Cowpea chlorotic mottle virus(CCMV) was maintained incowpea 
plants for use in subsequent inoculations of cowpea and soybean plants. 
Plant sap inoculum was prepared by grinding with a mortar and pestle a 
1:10 weight/volume ratio of systemically infected cowpea trifoliate 
leaves and cold 0.1 M, pH 5.0, sodium acetate buffer, containing 0.01 M 
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sodium diethyldithiocarbamate (NaDIECA) and 0.01 M cysteine hydrochlor¬ 
ide. The inoculum was strained through several layers of cheesecloth 
and then stored on ice at 0°C while inoculations were performed. 
Inoculation was carried out by first dusting the primary leaves 
of plants with 600-mesh carborundim. The inoculun was applied by 
gently rubbing a bent glass rod dipped in inoculum once over the surface 
of each primary leaf. Inoculated leaves were then rinsed with tap 
water. Chlorotic mottling appeared on the trifoliate leaves of cowpea 
plants within 10-14 days after inoculation. Local lesions appeared 
on the primary leaves of soybean plants within 24-48 hours after inocu¬ 
lation and were counted on half leaves using a hand lense. 
Purification. Purified CCMV was obtained by differential centifugation 
according to a modified procedure of Gay and Kuhn (1968). Approximately 
200 grams of systemically infected trifoliate leaves were harvested 
from cowpea plants 10-14 days after the plants were inoculated. The 
plant tissue was homogenized for 3 minutes in a Waring blendor with 
2.0 M,pH 5.0 sodium acetate buffer (containing 0.01 M NaDIECA and 0.01 M 
cysteine hydrochloride), chloroform, and butanol (1.0 ml of each per 
gram of tissue). All solutions were chilled prior to purification and 
the preparation was kept on ice in order to maintain it between 0° and 
4°C. After straining the homogenate through 8 layers of cheesecloth, 
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it was centrifuged for 10 minutes at 1600 g in a Sorvall RC-2B refrig¬ 
erated centrifuge. The supernatant was removed and centrifuged for 
10 minutes at 25,000 g. The supernatant was once again removed and 
centrifuged for 1 hour at 98,000 g in a Beckman L2-65B ultracentrifuge. 
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Each pellet was suspended in 1 ml of cold 0.1 M, pH 5.0, sodium acetate 
buffer, containing 0.01 M MgCl^ (Dawson and Kuhn, 1972), using a glass 
homogenizer. The homogenate was then centrigured for 10 minutes at 
20,000 g. The supernatant was removed and centrifuged for 1 hour at 
138,000 g. Each pellet was suspended in 0.1 M, pH 5.0, sodium acetate 
buffer, containing 0.01 M MgCl2. The homogenate was centrifuged at 
20,000 g. The supernatant was removed and centrifuged for 1 hour at 
138,000 g. Each pellet was again suspended in 0.01 M, pH 5.0, sodiiin 
acetate buffer, containing 0.01 M MgCl^. The homogenate was centrifuged 
once more at 20,000 g. The supernatant contained purified CCMV in 
buffer. The amount of virus nucleoprotein was estimated by measuring 
the optical density at 260 nm using a Beckman DB-G grating spectro¬ 
photometer. A virus nucleoprotein concentration of 1 mg/ml has an 
optical density of 6.0 (Dawson and Kuhn, 1972). Yields of purified 
CCMV ranged from 0.2 to 0.6 mg per gram infected plant tissue. The 
purified CCMV preparation was stored at 4°C until used. 
The Antiserum 
Production. Purified CCMV was suspended in 0.01 M, pH 7.0, phosphate 
buffer, containing 0.85% NaCl, (PBS) for injection into rabbits. A 
preparation of purified CCMV nucleoprotein, suspended in acetate buffer, 
was centrifuged for 1 hour at 138,000 g. The pellets were suspended and 
homogenized in PBS. The homogenate was centrifuged at 20,000 g. The 
supernatant contained purified CCMV nucleoprotein suitable for use as 
antigen in the production of CCMV antisera. Two rabbits were immunized 
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and bled according to the procedure of Otsuki and Takebe (1969). Each 
rabbit was injected intravenously with 10 mg of purified CCMV antigen in 
1 ml PBS. Four days later, the rabbits received intramuscular injec¬ 
tions of 50 mg CCMV in 1.2 ml PBS emulsified with an equal volume of 
Freund's complete adjuvant. After 1 month a final intravenous injec¬ 
tion of 10 mg CCMV in 0.8 ml PBS was injected into each rabbit. The 
rabbits were bled by cardiac puncture using a 50 cc sterile plastic 
syringe 10 days after the last immunization. Food was withheld from 
the rabbits for 16 hours before bleeding to reduce serum lipids. 
The antiserum was prepared according to the procedure of Williams 
and Chase (1967). The blood was allowed to clot for 1 hour at 37°C in 
sterile 50 ml plastic centrifuge tubes. The tubes were rirrmed with a 
wooden applicator stick and refrigerated overnight at 4°C for clot con¬ 
traction. The clot was removed and the serum was centrifuged for 20 
minutes at 300 g in a Sorvall RC-2B refrigerated centrifuge to remove 
blood cells. Complement was inactivated by incubating the serum at 
56°C for 20 minutes. The serum was stored in 3 ml serum vials and 
frozen until used. 
Titer and specificity. The antiserum from each rabbit was titered by 
> 
using the microprecipitin test according to a modified procedure of 
Ball (1974). Grid patterns were drawn on microprecipitin plates so 
that serial dilutions of CCMV-antiserim (from each rabbit) or normal 
rabbit serum and antigen (purified CCMV) could be placed in each square. 
Normal rabbit serum was included to be certain that a nonspecific 
precipitin reaction was not occurring between CCMV antigen and rabbit 
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serum proteins. Each serum was serially diluted in 0.01 M, pH 5.0, 
sodium acetate buffer. One ul drop of each serial dilution of anti¬ 
serum and CCMV antigen was placed in each square on a microprecipitin 
plate. The drops of antiserum and antigen in each square were gently 
mixed with wooden applicator sticks. The same procedure was carried 
out with normal rabbit serim and CCMV antigen. The plates were incu¬ 
bated overnight at 4°C in a moisture chamber. They were observed the 
following day under a light microscope for the presence of a cloudy, 
white precipitate. The greatest antiserum dilution at which a preci¬ 
pitate was seen represented the titer of the antiserum. The antiserun 
titers for both rabbits were between 1/800 and 1/1600. 
Specificity of the antisera for CCMV antigen, as opposed to normal 
plant tissue antigens, was demonstrated by the Ouchterlony gel double 
diffusion test and the viral neutralization test. 
Ouchterlony plates were prepared by dissolving 0.9 g Agarose agar 
in 100 ml 0.01 M, pH 7.0, PBS. The agar was autoclaved for 18 minutes 
and preserved by the addition of 0.025% sodium azide. The agar was 
poured into sterile disposable plastic petri plates. After the agar 
had solidified, 7 wells were cut using a size 5 cork borer. The center 
well contained CCMV antiserum diluted 1:10 in PBS. The six surround¬ 
ing outer wells contained ei ther purified CCMV antigen (100 ug/ml in 
sodium acetate buffer), CCMV-infected plant sap, or healthy plant sap 
(both diluted 1:10 in sodium acetate buffer). The plates were incu¬ 
bated in a moisture chamber for one week at 4°C. Precipitin bands 
formed only between purified CCMV antigen and CCMV antiserun and 
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between CCMV-infected plant sap and CCMV antiserun but never between 
healthy plant sap and CCMV antiserum. 
For virus neutralization, CCMV antiserun was serially diluted with 
PBS. One ml of each serial dilution was incubated with 1 ml purified 
CCMV antigen (100 ug/ml) for 30 minutes. Each mixture was then inocu¬ 
lated onto the primary leaves of soybean plants (6 leaves/treatment). 
After 48 hours, the presence of antiserum (diluted up to 1:1600) in the 
inoculum was seen to reduce local lesion numbers. Neutralization of 
virus infectivity suggested that the antiserum contained antibodies 
specific for CCMV. 
The Antiviral Compounds 
Preparation of antiviral compounds. Each compound was applied onto 
cowpea and soybean plants at the highest concentration determined to be 
nontoxic. 2-Thiouracil (supplied by Sigma Chemical Co., St. Louis, 
Missouri) and ribavirin, trademark named Virazole, (supplied by ICN 
Pharmaceuticals, Irvine, California) were suspended at a concentration 
of 500 mg per liter distilled, deionized water. Amantadine (supplied 
by Pfaltz and Bauer, Inc., Stamford, Connecticut) was suspended at a 
concentration of 250 mg per liter distilled, deionized water. Methi- 
sazone, trademark named Marboran, (supplied by Burroughs Wellcome Co., 
Research Triangle Park, North Carolina) was suspended in 1 N NaOH which 
was further diluted 1:10 with distilled, deionized water to give a 
final methisazone concentration of 250 mg per liter. Formycin, trade¬ 
mark named Formycin B, (supplied by Sigma Chemical Co., St. Louis, 
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Missouri) was suspended at a concentration of 25 mg per liter distilled, 
deionized water. Bavistin (supplied by B.A.S.F., Aktiengesellschaft, 
West Germany), a commercial preparation containing 50% (w/w) methyl 
benzimidazol-2yl-carbamate in non-active filler, was suspended at a 
concentration of 1,000 mg per liter distilled, deionized water. 
Method of application. Both cowpea and soybean plants were sprayed with 
the antiviral compounds using DeVilbiss Non-Corrosive 251 Atomizers. 
The plants were sprayed with a fine mist until droplets began to coal¬ 
esce to assure even coverage of the leaves. 
Timing of compound application. Six spray regimes (Treatments A-F) were 
followed for the application of the antiviral compounds. The compounds 
were sprayed as follows: 
Treatment A—2 days and 1 day before inoculation and at the 
time of inoculation. 
Treatment B--2 days and 1 day before inoculation, at the time 
of inoculation, and 1 day after inoculation. 
Treatment C—At the time of inoculation. 
Treatment D—At the time of inoculation and 1 day after 
inoculation. 
Treatment E—At the time of inoculation and 1 day, 2 days, 
3 days, and 4 days after inoculation. 
Treatment F—1 day, 3 days, 6 days, and 8 days after inocu¬ 
lation. 
Plants were always inoculated in the morning. When plants were sprayed 
on the day of inoculation, spraying took place immediately after 
inoculation. 
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Experimental Design 
Direct in vitro effects of antiviral compounds on CCMV infectivity. The 
direct or in vitro effects of the antiviral compounds were tested to 
determine whether any of the compounds directly influenced the infec¬ 
tivity of the CCMV inoculum or the infection process. Systemically 
infected tissue from cowpea plants was homogenized in 0.1 M, pH 5.0, 
sodium acetate buffer containing 0.01 M NaDIECA and 0.01 M cysteine 
hydrochloride to give a 1:5 plant sap dilution. Double strength spray 
solutions were made for each of the six compounds. Three ml of plant 
sap were mixed with 3 ml of each spray solution. The mixtures were 
allowed to incubate for 1 hour at 4°C. The pH of each mixture was 
determined using a pH meter. Each mixture was inoculated onto 8 soybean 
primary leaves. Control plants were inoculated with a mixture contain¬ 
ing 3 ml of plant sap and 3 ml of distilled, deionized water. Local 
lesions were counted after 48 hours. 
Effects of antiviral compounds on local lesion formation on soybean 
plants. Preliminary experiments were done to examine the effects of 
2-thiouracil, ribavirin, amantadine, methyl benzimidazol-2yl-carbamate, 
methisazone, and formycin on local lesion formation on soybean plants. 
The six compounds were applied using spray treatments A, B, C, and D. 
The control consisted of plants which were inoculated without being 
sprayed. Eight soybean primary leaves were inoculated and local lesions 
were counted after 48 hours. 
Further testing of ribavirin, amantadine, formycin, and methisazone 
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was accomplished by spraying the soybean plants three times on the day 
of inoculation. Plants were sprayed at 8:00 A.M., 12:00 A.M., and 
5:00 P.M. while inoculation was carried out at approximately 11:00 A.M. 
A spreader-sticker was added to each spray solution at a concentration 
of 50 ul in 30 ml of solution. Controls consisted of inoculated soybean 
plants which were unsprayed, sprayed with distilled water, or sprayed 
with distilled water containing spreader-sticker. Inoculation of 
counting of local lesions were done according to the procedures pre¬ 
viously described. 
Effects of antiviral compounds on systemic CCMV infection of cowpea 
plants. Preliminary experiments were done to determine what effects, 
if any, the six antiviral compounds exhibited on systemic infection of 
cowpea plants. The six compounds were applied using spray treatments, 
A, B, C, D, E, and F. The positive control consisted of plants which 
were inoculated with CCMV without being sprayed. The negative control 
consisted of plants which were sprayed without being inoculated. To 
determine the effects of the antiviral compounds on the infectivity 
of CCMV within the systemically infected plants, infectivity assays 
were performed on soybean plants using cowpea tissue from each treatment 
as an inoculum source. To prepare the inoculum, six primary leaves 
were randomly selected from cowpea plants receiving a ,given treatment. 
The six leaves were shredded into small 3 mm pieces with a razor blade. 
Using a mortar and pestle, 0.5 g of shredded leaf tissue was homogenized 
with 4.5 ml of pH 5.0, 0.1 M., sodium acetate buffer containing 0.01 M 
NaDIECA and 0.01 M cysteine hydrochloride. Eight soybean primary leaves 
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were inoculated and local lesions were counted according to the proce¬ 
dures previously described. These assays were performed 10 days after 
the cowpea plants were inoculated. Visual observations were recorded 
10 days and 42 days after inoculation to determine the effects of each 
compound on symptom development and plant growth. 
A second set of experiments were done to further test four of the 
antiviral compounds which appeared to have an effect on systemic CCMV 
infection of cowpea plants in the preliminary experiments. 2-Thiouracil, 
ribavirin, amantadine, and methisazone were applied using spray treat¬ 
ments A, C, and E. The control plants were inoculated without being 
sprayed. Infectivity assays were performed according to the procedure 
described in the preliminary experiment. Two infectivity assays were 
performed 10 days after inoculation using either the primary leaves or 
the trifoliate leaves as an inoculum source. Two additional infectivity 
assays were performed 16 and 22 days after inoculation using trifoliate 
leaves as an inoculum source. 
A final set of experiments was done to determine the effects of two 
of the antiviral compounds on the presence of CCMV antigen within 
systemically infected cowpea plants. Ribavirin and amantadine were 
applied using spray treatment E. The controls consisted of healthy 
plants which were not inoculated or sprayed and inoculated plants which 
were not inoculated or sprayed and inoculated plants which were not 
sprayed. The enzyme-linked immunosorbent assay (ELISA) was performed 
2, 4, 8, and 15 days after inoculation. Randomly selected primary 
leaves (at 2, 4, and 8 days after inoculation) and trifoliate leaves (at 
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15 days after inoculation) from each treatment were homogenized in the 
ELISA virus (conjugate) buffer (see below) using a mortar and pestle to 
give 1:10 (w/v) dilutions of plant sap in which the presence of viral 
antigen could be detected. Separate ELISA tests were performed on each 
of the 4 replications of each antiviral compound spray treatment. 
The Enz.yme-Linked Immunosorbent Assay 
The enzyme-linked immunosorbent assay (ELISA) was performed in 
accordance with the procedures of Clark and Adams (1977). 
Preparation of buffers and glassware. Several buffers and solutions were 
prepared for ELISA. Coating buffer was prepared by adjusting the pH of 
0.05 M sodium carbonate buffer to 9.6 with HCl. PBS-Tween washing solu¬ 
tion was prepared by adding 0.15 M NaCl and 0.05% (v/v) Tween 20 to 
0.02 M, pH 7.4, phosphate buffer. Conjugate (virus) buffer was pre¬ 
pared by adding 2.0% (w/v) polyvinylpyrrolidone (MW 10,000) and 0.2% 
(w/v) ovalbumin to PBS-Tween. Substrate buffer was prepared by adjust¬ 
ing the pH of 10% (v/v) diethanolamine to pH 9.8 with HCl. A solution 
of 3 M NaOH was prepared to stop enzyme activity before the ELISA plates 
were read. Sodium azide (0.02% w/v) was added to all buffers to prevent 
contamination. 
Any glassware which contained antibodies was siliconized with 
Sigmacote to prevent loss of protein by absorption. 
Immunoglobulin G purification. One ml samples of CCMV antiserum were 
diluted with 9 ml distilled, deionized water. Ten ml of saturated 
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ammonium sulphate solution were added slowly while stirring to 10 ml 
of diluted antiserum. After the mixture was allowed to stand for 1 
hour at room temperature, it was centrifuged for 5 minutes at 4,000 g to 
collect the precipitate. The precipitate was dissolved into 2 ml of 
half-strength PBS. The sample was then dialyzed overnight at 4®C against 
500 ml of half-strength PBS with 2 changes of the buffer during the 
dialysis. 
Further purification of IgG was achieved by passing the sample 
through a short chromatographic column which was packed to a height of 
5 cm with DE 22 cellulose (Whatman, Inc.). DE 22 cellulose was pre¬ 
equilibrated in half-strength PBS and prepared for use according to the 
manufacturer's instructions. Malachite green dye was passed through the 
packed column to make certain the column was properly packed before the 
IgG sample was loaded onto the column. Once a sample was loaded onto 
the column, the column was washed with half-strength PBS until purified 
IgG protein was eluted. Two ml fractions were collected and monitored 
spectrophotometrically at 280 nm. The fraction containing purified 
IgG (unabsorbed protein) was eluted soon after the void volume. The 
peak fraction had an optical density of 2.84 at 280 nm. The presence 
of purified IgG was confirmed by a positive precipitin reaction with 
purified CCMV antigen. The purified IgG was diluted in half-strength 
PBS until an optical density of 1.4 was obtained to give a concentration 
of approximately 1 mg/ml. It was then stored in siliconized glass 
tubes at 4°C. 
Con.iuqation of enzyme with IgG. A liquid preparation containing 2 mg of 
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Sigma No. P-4502 Type VII alkaline phosphatase in 0.001 M MgCl^ and 
0.0001 M ZnCl^ was centrifuged at 4,000 g for 5 minutes. The superna¬ 
tant was discarded and the precipitate was dissolved by direct addition 
of 1 ml (=1 mg) of purified IgG to the centrifuge tube. The preparation 
was dialized against 500 ml PBS overnight at 4°C with 2 changes of the 
buffer during dialysis. After dialysis, 25 % glutaraldehyde solution 
was mixed with the IgG preparation to give a final glutaraldehyde con¬ 
centration of 0.05% (v/v). The mixture was incubated for 4 hours at 
room temperature after which time a very faint sandy brown color devel¬ 
oped. The conjugate preparation was dialzyed overnight at 4°C against 
500 ml PBS with 0.01% sodium azide with 2 buffer changes during the 
dialysis. After the addition of 5 mg/ml bovine serum albumin, the 
conjugate was stored at 4°C in a siliconized glass test tube. 
ELISA procedure. Purified IgG was diluted 1:10,000 in coating buffer 
to give an optimum concentration of 0.1 ug/ml coating IgG. The wells of 
the ELISA plates (Gilford Instruments, Inc.) were each coated with 200 
ul of coating IgG. Outer wells which were not used were filled with 
distilled water throughout this procedure. The plate was covered with 
Saran Wrap and incubated in a moisture chamber for 4 hours at 37°C or 
overnight at 4°C. The wells were washed by flooding them with PBS- 
Tween and allowing them to sit for 3 minutes before emptying the plate. 
After the wells were washed 3 times, test samples diluted in virus 
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(conjugate) buffer and filtered through 2 layers of Miracloth were 
added in 200 ul aliquots to the coated wells. The plate was incubated 
and washed as described above. Alkaline phosphatase conjugated IgG was 
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diluted 1:1600 in conjugate buffer to give an optimum concentration of 
conjugated IgG. The conjugate was added in 200 ul aliquots to each well. 
The plate was incubated and washed as described above. P-nitrophenyl 
phosphate tablets were dissolved into substrate buffer to give a final 
substrate concentration of 1 mg/ml. Substrate was added in 300 ul 
aliquots to each well. After a 1-hour incubation at room temperature, the 
reaction was stopped by the addition of 50 ul 3 M NaOH to each well. 
The results were determined within a half hour by quantitating the 
absorbance of the hydrolyzed substrate at 405 nm using a Gilford EIA 
processor/reader. 
Determination of optimum coating IgG and enz.yme-conjugated IgG concen¬ 
trations. The ELISA procedures described above were used to determine 
optimum concentrations of coating and enzyme-conjugated IgG. The wells 
of an ELISA plate were coated with serial dilutions of coating IgG 
(10, 1.0, and 0.1 ug/ml) in coating buffer. Three replicates of each 
coating IgG concentration were used. Each of the three replicates re¬ 
ceived either a 1:200, a 1:800, or a 1:3200 dilution of enzyme conju¬ 
gated IgG. The following test samples were used: 1:10, 1:100, 
1:1,000 (w/v) dilutions of virus-infected tissue in virus (conjugate) 
buffer: 1:10 and 1:100 (w/v) dilutions of healthy tissue in virus 
(conjugate) buffer; and virus conjugate buffer. Optimum concentra¬ 
tions were determined spectrophotometrically as those concentrations of 
coating and enzyme-conjugated IgG which produced A^q^ readings between 
0 and 2.0. 
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Statistical Analysis 
Statistical analysis of local lesion numbers and ELISA A.^^ read¬ 
out) 
ings was done by a one-way analysis of variance for the variable experi¬ 
mental treatment (Zar, 1974). For analysis of local lesion numbers, 
the mean values of 8 local lesion numbers (from 8 primary half leaves 
of soybean plants) were used to represent each experimental treatment. 
Since 4 replications of each experimental treatment were performed in 
all experiments, the group mean of the 4 replications for each experi¬ 
mental treatment were determined. Analysis of ELISA A^q^ readings was 
accomplished by using the group mean values from 4 replications of 
each experimental treatment. The Duncan new multiple range test was 
used for a comparison of the group means to determine which experimental 
treatments produced significantly different effects on CCMV infectivity 
at the 0.05 level of significance (Zar, 1974). 
Since local lesion numbers deviate greatly from a normal frequency 
distribution, analysis of variance by the Duncan new multiple range 
test was also performed on local lesion numbers which were transformed 
according to the procedure of Kleczkowski (1955). The transformation 
z=logio (x+c) was used when local lesion numbers were greater than 10, 
where x=number of lesions and c=5. Numbers less than 10 were trans- 
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formed according to the formula z=logiQ i(x+c+/^2^2cx^ * however, 
transformed local lesion numbers are only presented when they exhibit 
differences among experimental treatments which were not evident from 
the analysis of untransformed local lesion numbers. 
CHAPTER IV 
RESULTS 
Effects of Antiviral Compounds on the Development 
of Viral Symptoms and Plant Growth 
Six antiviral compounds namely 2-thiouracil, ribavirin, amantadine, 
formycin, methisazine, and methyl benzimidazol-2yl-carbamate, were 
applied on cowpea leaves according to spray treatment regimes A, B, 
C, D, E, or F (described in Materials and Methods). Their effects 
on CCMV symptom expression and their toxicity to plant growth were det¬ 
ermined by visual observations recorded 10 and 42 days after the inocula¬ 
tion of cowpea plants. Symptom development and plant growth were com¬ 
pared to that of unsprayed, inoculated and sprayed, uninoculated control 
plants. 
Cowpea plants inoculated with CCMV and sprayed with 2-thiouracil, 
treatments A, E, and F, exhibited severe CCMV symptoms consisting of 
chlorotic mottling 10 days after inoculation, while plants sprayed with 
2-thiouracil, treatments B, C, and D, exhibited slight chlorotic mottl¬ 
ing when comparedwith the unsprayed, inoculated control plants (Fig. 1 
and Fig. 2). Inoculated and uninoculated plants sprayed according to 
any of the treatment regimes (A through F) exhibited symptoms of toxi¬ 
city which included stunting of plant growth, bleaching of primary and 
trifoliate leaves, and puckering of trifoljate leaf margins (Fig. 2). 
Forty-two days after inoculation, sprayed cowpea plants still exhibited 
puckering of young, newly expanded, trifoliate leaf margins. Symptoms 
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Fig. 1. Chlorotic mottling on trifoliate leaves of cowpea plants 
systemically infected with cowpea chlorotic mottle virus observed ten 
days after inoculation. 
Fig. 2. Reduction (left) and increase (right) in symptom develop¬ 
ment of cowpea chlorotic mottle virus-infected cowpea plants caused by 
different 2-thiouracil treatments within ten days after inoculation. 
Stunting, bleaching, and puckering of trifoliate leaves were toxic 
effects caused by 2-thiouracil application. 
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of CCMV continued to remain severe with treatments A, E, and F while 
with treatmentsB and D symptoms became severe on young trifoliate leaves 
of plants observed 42 days after inoculation. Symptoms developed only 
slightly on plants sprayed according to treatment C and observed 42 
days after inoculation. 
Application of ribavirin, treatments A through F, caused cowpea 
plants to remain almost completely free of CCMV symptoms during the 10 
days after inoculation. No toxic effects were exhibited on the plants 
when sprayed according to any of the six treatment regimes (Fig. 3). 
When the cowpea plants were observed 42 days after inoculation, they 
still did not exhibit any symptoms of toxicity. In addition, young tri¬ 
foliate leaves of plants sprayed with treatments E and F were completely 
free of CCMV symptoms 42 days after inoculation while those sprayed with 
treatment A exhibited only very faint symptoms. Young trifoliates of 
plants sprayed according to treatments B, C, and D exhibited more severe 
symptoms at 42 days after inoculation than did trifoliates at 10 days 
after inoculation but the symptoms were milder than those exhibited 42 
days after inoculation by unsprayed, control plants. 
Amantadine, applied according to treatments A through F, reduced 
the chlorotic mottling symptoms of CCMV-infected cowpea plants observed 
10 days after inoculation. Treatments A, B, C, and D resulted in almost 
complete suppression of CCMV symptoms, while treatments E and F allowed 
mild symptom development during the first 10 days after inoculation. 
Trifoliate leaves showed minimal margin necrosis when amantadine was 
applied according to treatments E and F on both sprayed inoculated and 
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Fig. 3. Inhibition of cowpea chlorotic mottle virus symptom 
development and absence of toxic effects observed ten days after inocu¬ 
lation when cowpea plants were sprayed with ribavirin. 
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sprayed, uninoculated control plants (Fig. 4) when observed 10 days after 
inoculation. Forty-two days after inoculation, some leaf margin necro¬ 
sis was still observed on trifoliate leaves of cowpea plants sprayed 
according to treatments E and F. Young trifoliate leaves on plants 
sprayed according to treatments A, B, C, and D were almost completely 
free of CCMV symptoms when observed 42 days after inoculation. Treat¬ 
ments E and F allowed the development of some symptoms on young trifoli¬ 
ate leaves 42 days after inoculation but these were much less severe 
than the symptoms of unsprayed,inoculated control plants. 
Formycin, although nontoxic to the directly sprayed primary leaves 
of cowpea plants, was highly toxic to young, newly expanding, trifoli¬ 
ate leaves of sprayed,inoculated plants and sprayed,uninoculated control 
plants. The toxic effects included leaf margin necrosis, leaf pucker¬ 
ing and curling, and the formation of necrotic 'shot-hole' lesions on 
trifoliate leaves. The development of CCMV symptoms was inhibited by 
formycin treatments A, B, C, D, and E when evaluated 10 days after inoc¬ 
ulation (Fig. 5). At 42 days after inoculation, the toxic effects 
caused by formycin were less severe than at 10 days after inoculation. 
CCMV symptoms in young trifoliate leaves observed 42 days after inocula¬ 
tion were reduced by treatments A, B, C, and D just as they were 10 
days after inoculation; however, treatment E was no longer as effective 
in reducing symptom development. Young trifoliates of plants sprayed 
according to treatments E and F exhibited CCMV symptoms as severe as the 
symptoms on unsprayed, inoculated control plants 42 days after inocula- 
ti on. 
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Fig. 4. Amantadine induced reduction in cowpea chlorotic mottle 
virus symptom development of cowpea plants within 10 days after inocula¬ 
tion. 
Fig. 5. Severe phytotoxicity but reduction in cowpea chlorotic 
mottle virus symptom development observed on cowpea plants ten days 
after inoculation as a result of formycin application. 
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Application of methisazone treatments A through F inhibited CCMV 
symptom development of cowpea plants observed 10 days after inoculation. 
All methisazone treatments induced severe toxic effects consisting of 
striation and narrowing of trifoliate leaves in both sprayed,inoculated 
and sprayed,uninoculated control plants observed 10 days after inocula¬ 
tion (Fig. 6). Forty-two days after inoculation, these toxic effects 
were no longer observed on trifoliate leaves. CCMV symptoms were absent 
in young trifoliates of plants sprayed with treatments A through F and 
observed 42 days after inoculation. 
Cowpea plants sprayed with methyl benzimidazol-2yl-carbamate ac¬ 
cording to treatments A through F, exhibited CCMV symptoms that were 
comparable to the symptoms on unsprayed,inoculated control plants with 
no evidence of any toxic effects throughout the 42 days of observation 
(Fig. 7). 
Direct In Vitro Effects of Antiviral 
Compounds on CCMV Infectivity 
Mixtures of each antiviral compound and plant sap from CCMV- 
infected cowpea leaves were incubated for 1 hour at 4°C to determine 
the direct effects, if any, of each compound on the infectivity of CCMV. 
The in vitro effects were determined by performing infectivity assays 
using the antiviral compound-CCMV infected sap mixtures as the inoculum. 
> 
When local lesion numbers were compared only methisazone directly re¬ 
duced CCMV infectivity significantly. This was apparently due to the 
elevation of the pH of the inoculum when mixed with methisazone. When 
transformed local lesion nunbers were compared, treatment of CCMV in sap 
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Fig. 6. Formation of narrow, striated trifoliate leaves and re¬ 
duced cowpea chlorotic mottle virus symptom development observed on 
methisazone-treated cowpea plants observed ten days after inoculation. 
Fig. 7. Absence of toxic effects and presence of normal cowpea 
chlorotic mottle virus symptoms on trifoliate leaves of cowpea plants 
sprayed with methyl benzimidazol-2yl-carbamate and observed ten days 
after inoculation. 
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with either methisazone or ribavirin reduced CCMV infectivity signifi¬ 
cantly (Table 1). 
Effects of Antiviral Compound Sprays on Formation 
of Local Lesions on Soybean Plants 
The six antiviral compounds namely 2-thiouracil, ribavirin, amanta¬ 
dine, formycin, methisazone, and methyl benzimidazol-2yl-carbamate were 
sprayed on soybean plants according to treatment regimes A through D 
and the soybean primary leaves were inoculated with CCMV-containing 
sap from systemically infected cowpea leaves. The number of local 
lesions produced on the soybean primary leaves 48 hours after inocula¬ 
tion was taken as a measure of the effect of each antiviral compound on 
local lesion formation of CCMV. Although each of the compounds, with 
all treatment regimes, reduced the number of local lesions formed, the 
lesion numbers were not significantly lower than those on unsprayed, in¬ 
oculated control soybean plants (Table 2). Transformed local lesion 
numbers yielded no further statistically significant differences. Local 
lesion size remained the same in the control plants and in plants re¬ 
ceiving the various treatments. 
Effects of Antiviral Compounds on Formation 
of Local Lesions on Soybean Plants Receiving 
Three Spray Applications on Day of Inoculation 
Ribavirin, amantadine, formycin, and methisazone were applied on 
> 
soybean plants three times (at 8:00 A.M., 12:00 A.M., and 5:00 P.M.) on 
the day of their inoculation with CCMV in order to test further the 
effect of these compounds on local lesion formation. Each compound was 
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TABLE 1 
Effect of Antiviral Compounds on pH and Infectivity of 
Cowpea Chlorotic Mottle Virus Inoculum 
Antiviral 
Compound 
Inoculurn 
pH 
Inoculurn 
Infectivi ty^ 
Local Lesion . 
Transformation^ 
2-Thiouracil 5.7 73.00+66.03 1.73 
Ribavirin 5.7 48.97 + 46.96 1.58* 
Amantadine 5.2 65.38 + 44.60 1.77 
Formycin 5.3 104.94 + 17.09 2.04 
Methisazone 11.0 0.03*+ 0.07 0.41* 
Methyl benzimidazol- 
2yl-carbamate 6.3 85.47 + 28.57 1.94 
Control--No Compound 5.5 85.72 + 29.50 1.94 
^Each number represents the mean number of local lesions of 4 replica¬ 
tions + the standard deviation. Each replication consists of 8 soybean 
leaves. 
^Each number represents a logarithmic transformation of the mean number 
of local lesions (Kleczkowski, 1955). 
*Statistically significant difference in infectivity between antiviral 
compound and control when analyzed by the Duncan new multiple range 
test (P=0.05). 
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mixed with a spreader-sticker before it was sprayed on the plants. The 
nunbers of local lesions produced on plants sprayed with the four anti¬ 
viral compounds were significantly lower than those produced on inocu¬ 
lated control plants that were left unsprayed, sprayed with distilled 
water, or sprayed with distilled water containing spreader-sticker. 
Furthermore, the number of local lesions produced on methisazone- 
treated plants was significantly lower than the number of local lesions 
produced on plants treated with any of the other antiviral compounds. 
Transformed local lesion numbers yielded no further significant differ¬ 
ences. Local lesion numbers were also lower on inoculated control plants 
sprayed with a mixture of distilled water and spreader-sticker, but 
these numbers were not significantly lower than the number of local 
lesions produced on unsprayed plants (Table 3). None of the antiviral 
treatments affected the size of individual local lesions. 
Effects of Antiviral Compound Sprays on 
Infectivity of CCMV in Cowpea Plants 
The antiviral compounds 2-thiouraci1, ribavirin, amantadine, formy- 
cin, methisazone, and methyl benzimidazol-2yl-carbamate were sprayed on 
CCMV-infected cowpea plants according to spray treatment regimes A, B, 
C, D, E, and F. The treated plants were assayed for virus infectivity, 
as determined by the number of local lesions produced on soybean plants 
(Fig. 8), by harvesting the primary leaves of the treated cowpea plants 
10 days after inoculation and using them as a source of inoculum for the 
inoculation of soybean plants. 
The treatments were evaluated for their effects on the infectivity of 
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TABLE 3 
Effect of Antiviral Compound Sprays, Applied 3 Times on the 
Day of Inoculation, on the Number of Cowpea Chlorotic Mottle Virus 
Local Lesions on Soybean Plants 
Spray 
Treatment 
Number of 
Local Lesions* 
Methisazone 3.07® + 1.42 
Ribavirin 6.57^ + 2.61 
Amantadine 8.38^ + 1.81 
Formycin 9.03*’ + 4.43 
Control--Distilled H^O 
and Spreader-Sticker 
16.72'^ + 2.54 
Control—Distilled H^O 27.51^ + 2.26 
Control—No Spray 29.38^ + 2.86 
*Each number represents the mean number of local lesions of 4 replica¬ 
tions + the standard deviation. Each replication consists of 8 soy¬ 
bean half leaves. Means followed by a common letter are not signifi¬ 
cantly different. The local lesion numbers were statistically analyzed 
by the Duncan new multiple range test (P=0.05). 
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Fig. 8. Local lesions on primary leaves of soybean plants observed 
24 to 48 hours after inoculation. 
46 
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CCMV in cowpea plants by comparing the infectivity of CCMV in sap from 
sprayed plants to that of unsprayed, inoculated control plants (Table 4). 
Although many of the treatments caused some decrease in CCMV infectivity, 
none of these were significantly lower than the infectivity of sap 
from unsprayed, inoculated control plants. The six compounds reduced 
CCMV infectivity in cowpea plants when applied according to the follow¬ 
ing spray treatment regimes: 2-thiouracil, A, B, C, and D; ribavirin, 
A, B, C, D, E, and F; amantadine. A, B, C, D, and E; formycin. A, B, and 
C; methisazone. A, B, C, D, and E; methyl benzimidazol-2yl-carbamate, A, 
B, C, E, and F. Eight of the treatments caused some increase in CCMV 
infectivity. These were: E and F for 2-thiouracil; F for amantadine; 
D, E, and F for formycin; F for methisazone; and D for methyl benzimida- 
zol-2yl-carbamate. 2-Thiouracil treatments E and F increased infectiv¬ 
ity significantly (Table 4). Transformed local lesion numbers yielded 
no further significant differences. 
Effects of Antiviral Compounds on Infectivity of CCMV in 
Cowpea Plants at 10, 16, and 22 Days After Inoculation 
Four of the antiviral compounds namely 2-thiouracil, ribavirin, 
amantadine, and methisazone which appeared to have the greatest effects 
on CCMV infectivity and on symptom development 10 days after inocula¬ 
tion, were further tested for their effects on CCMV infectivity in cow¬ 
pea plants. Infectivity assays were performed 10 days after inoculation 
using as inoculum either the inoculated primary leaves or the first tri¬ 
foliate leaves. The purpose of this experiment was to determine whether 
CCMV infectivity in the younger trifoliates was more or less sensitive 
E
ff
e
c
t 
o
f 
A
n
ti
v
ir
a
l 
C
om
po
un
d 
S
p
ra
y
s 
on
 
In
fe
c
ti
v
it
y
 
o
f 
C
ow
pe
a 
C
h
lo
ro
ti
c
 
M
o
tt
le
 
V
ir
u
s 
in
 
C
ow
pe
a 
P
la
n
ts
, 
A
ss
ay
ed
 
10
 
D
ay
s 
a
ft
e
r 
In
o
c
u
la
ti
o
n
 
48 
•*C 
E
ac
h 
nu
m
be
r 
re
p
re
se
n
ts
 
th
e 
m
ea
n 
nu
m
be
r 
o
f 
lo
ca
l 
le
si
o
n
s 
o
f 
4 
re
p
li
c
a
ti
o
n
s 
+ 
th
e 
st
an
d
ar
d
 
d
ev
ia
¬
 
ti
o
n
. 
E
ac
h 
re
p
li
c
a
ti
o
n
 
c
o
n
si
st
s 
o
f 
8 
so
y
b
ea
n
 
h
a
lf
 
le
a
v
e
s.
 
T
he
 
lo
c
a
l 
le
si
o
n
 
nu
m
be
rs
 
w
er
e 
an
al
y
ze
d
 
by
 
th
e 
D
un
ca
n 
ne
w
 m
u
lt
ip
le
 
ra
n
g
e 
te
s
t 
(P
=
0
.0
5
).
 
^
 
S
ta
ti
s
ti
c
a
ll
y
 
si
g
n
if
ic
a
n
t 
d
if
fe
re
n
c
e
 
b
et
w
ee
n
 
a
n
ti
v
ir
a
l 
co
m
po
un
d 
an
d 
c
o
n
tr
o
l.
 
49 
to the effects of the antiviral compounds than CCMV infectivity in the 
inoculated primary leaves. Trifoliate leaves were also used as inoculum 
when infectivity assays were performed at 16 and 22 days after inocula¬ 
tion to determine whether the antiviral compounds become more or less 
effective against the virus at later stages of infection. The compounds 
were applied according to spray treatment regimes A, C, and E. The 
treated cowpea plants were assayed for virus infectivity (as determined 
by the number of local lesions produced on soybean plants) by using 
tissue from treated plants as inoculum for inoculation of soybean plants. 
Local lesion numbers produced by sap from sprayed plants were compared 
to those produced by sap from unsprayed, inoculated control plants 
(Table 5). Transformation of local lesion numbers yielded no additional 
significant differences. 
When the primary leaves of treated cowpea plants were assayed, 
ribavirin, amantadine, and methisazone reduced virus infectivity but 
these reductions were not statistically significant (Table 5). 2- 
Thiouracil decreased virus infectivity when applied according to treat¬ 
ment A, but when it was applied according to treatments C and E, 2- 
thiouracil increased virus infectivity. 2-Thiouracil treatment E 
increased virus infectivity considerably over the virus infectivity in 
unsprayed control plants (Table 5). 
When infectivity of virus in trifoliate leaves was assayed 10 days 
after primary leaf inoculation, all of the antiviral compound treatments 
reduced CCMV infectivity in the sprayed cowpea plants. However, only 
plants sprayed with ribavirin treatment E had significantly lower virus 
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infectivity than unsprayed, inoculated control plants (Table 5). 
When infectivity of virus in trifoliate leaves was assayed 10 days 
after primary leaf inoculation, all of the antiviral compound treatments 
continued to reduce CCMV infectivity in the sprayed cowpea plants. 
However, none of these reductions were statistically significant when 
compared to the infectivity of inoculated control plants (Table 5). 
Infectivity assays performed 22 days after inoculation showed that 
CCMV infectivity was reduced in unsprayed, inoculated control plants as 
well as in plants sprayed with each of the antiviral compound treatments. 
Although CCMV-infected plants sprayed with 2-thiouracil, treatments A, 
C, and E; ribavirin, treatments A, and E; and methisazone, treatment E, 
had less infectivity than unsprayed, inoculated control plants, plants 
sprayed with ribavirin, treatment C; amantadine, treatments A, C, and E; 
and methisazone, treatments A and C had greater infectivity than inocu¬ 
lated, unsprayed control plants. The infectivity in the plants sprayed 
with these treatments, however, was not significantly different from 
that of inoculated, unsprayed control plants (Table 5). 
Effects of Ribavirin and Amantadine on the Presence 
of Viral Antigen in CCMV-Infected Cowpea Plants 
The presence of viral antigen was detected by the enzyme-linked 
> 
immunosorbent assay (ELISA) in CCMV-infected cowpea plants sprayed 
with ribavirin or amantadine according to spray treatment E. The ELISA 
tests were carried out at 2, 4, 8, and 15 days after inoculation. The 
absorbance of the ELISA reaction at 405 nm indicated the relative amount 
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of viral antigen present. In all ELISA tests, sap from healthy control 
plants gave significantly lower or zero absorbance readings due to 
background absorbance as a result of nonspecific reactions (Table 6). 
At 2 days after inoculation, sap from inoculated cowpea plants 
sprayed with ribavirin contained slightly less viral antigen than un¬ 
sprayed, inoculated control plant sap while sap from plants sprayed with 
amantadine contained slightly more viral antigen than unsprayed, inocu¬ 
lated control plant sap. However, neither one of the viral antigen 
concentrations were significantly different from the viral antigen 
concentration in unsprayed, inoculated control plants (Table 6). 
At 4 days after inoculation, sap from inoculated cowpea plants 
sprayed with ribavirin contained slightly less viral antigen than sap 
from unsprayed, inoculated control plants while sap from plants sprayed 
with amantadine contained slightly more viral antigen than sap from un¬ 
sprayed, inoculated control plants. However, these differences in viral 
antigen concentration were also not statistically significant (Table 6). 
Sap from inoculated cowpea plants sprayed with ribavirin and aman¬ 
tadine and assayed by ELISA 8 days after inoculation, contained less but 
not significantly lower viral antigen than inoculated control plants. 
When cowpea sap was assayed 15 days after inoculation, sap from 
plants treated with ribavirin and amantadine contained more viral anti¬ 
gen than inoculated control plants, but these differences were not 
> 
statistically significant either (Table 6). 
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CHAPTER V 
DISCUSSION 
Many of the antiviral compounds were very effective in suppressing 
the development of CCMV symptoms on inoculated cowpea plants. However, 
statistical analysis of the infectivities of CCMV in plants receiving 
the various antiviral compound treatments and in inoculated control 
plants seldom revealed statistically significant differences between 
the effects of the treatments and the untreated inoculated controls. 
This was probably due to the fact that the local lesion numbers obtained 
for each experimental treatment exhibited great variability which re¬ 
sulted in large standard deviations among the treatment means. Trans¬ 
formation of local lesion numbers according to Kleczkowski (1955) before 
statistical analysis also resulted in large standard deivations. In 
spite of the lack of statistically significant differences, certain con¬ 
sistent trends were observed in the effects of the antiviral compounds 
on CCMV infectivity. 
The antiviral compounds appeared capable of altering CCMV infecti¬ 
vity depending on the times at which compounds were applied and at 
which virus assays were performed in relation to the time of plant inoc¬ 
ulation. Changes in CCMV infectivity>in soybean plants sprayed with 
treatment regimes A, B, C, and D, prior to or immediately after inocula¬ 
tion, may indicate a compound effect on an early stage of the viral in¬ 
fection process (absorption, penetration, uncoating, or de novo RNA 
synthesis) since these effects were apparent within 48 hours after 
54 
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inoculation (at about the time local lesions appeared)(Table 2). 
Similar conclusions may perhaps be drawn from experiments in which 
CCMV-inoculated soybean plants were sprayed with the antiviral compounds 
3 times on the day of inoculation (Table 3). Changes in CCMV infectiv- 
ity that become evident in virus assays (Tables 4 and 5) or from obser¬ 
vations of virus symptom development within 10 days after inoculation 
(when peak CCMV infectivity is normally reached) probably indicate that 
the antiviral compound affects a later stage of the viral infection 
process (replication, maturation, or long distance movement). Changes 
in CCMV infectivity that become evident after 15 or more days from inoc¬ 
ulation of sprayed plants probably indicate that virus breakdown or 
stability was affected by the antiviral compound. Such changes were 
monitored by infectivity assays performed at 16 and 22 days after inocu¬ 
lation (Table 5) and observation of symptoms at 42 days after inocula¬ 
tion. In addition, since ribavirin and amantadine were most successful 
at suppressing virus symptom development without causing phytotoxicity, 
their effects on viral antigen concentration in sprayed cowpea plants 
were quantitatively determined by ELISA performed at 2, 4, 8 and 15 
days after inoculation to ascertain whether the compounds may have 
affected early or late stages of the viral infection process or virus 
breakdown. 
> 
Of the six antiviral compounds tested for their effects on CCMV 
infectivity, only methisazone and ribavirin may have directly affected 
the infectivity of CCMV in the inoculum (Table 1). Methisazone appears 
to have directly inactivated CCMV by elevating the pH of the inoculum 
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(Table 1) since the CCMV virion becomes unstable and noninfectious when 
exposed to a pH above 7.0 (Verduin, 1978). Although the pH of the 
inoculum containing methyl benzimidazol-2yl-carbamate was somewhat 
elevated at 6.3 (Table 1), there was no inhibitory effect on the infec- 
tivity of CCMV in the inoculum. The direct effect of ribavirin on the 
infectivity of CCMV could not be a pH effect since the addition of riba¬ 
virin did not change the pH of the inoculum to one in which CCMV would 
be unstable. It is possible that it is not the CCMV in the inoculum 
that is directly affected by ribavirin but rather the infectivity of 
CCMV in the plant possibly due to the entrance of ribavirin into the 
soybean plant during inoculation and subsequent interference of riba¬ 
virin with the CCMV infection process. Of the six antiviral compounds 
tested for their direct effects on CCMV infectivity, 2-thiouracil, 
ribavirin, and amantadine were previously determined by others to have 
no direct effects on the infectivity of certain viruses (Dawson and 
Kuhn, 1972; Lerch, 1977; Kato and Eggers, 1969), while no such informa¬ 
tion was available for formycin, methisazone, and methyl benzimidazol- 
2yl-carbamate. 
The early infection processes of CCMV in soybean plants may have 
been affected by all six antiviral compounds when applied prior to or 
immediately after inoculation according to spray treatment regimes A, 
B, C, and D (Table 2), and by methisazone, ribavirin, amantadine, and 
formycin when applied 3 times on the day of inoculation (Table 3). 
Although local lesion numbers on soybean plants were reduced by applica¬ 
tion of antiviral compounds in both experiments (Tables 2 and 3), 
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statistically significant reductions in local lesion numbers were only 
observed when soybean plants were sprayed 3 times on the day of inocula¬ 
tion with antiviral compounds (Table 3). The significant reductions in 
local lesion numbers shown in Table 3 are probably the result of in¬ 
creased uptake of the antiviral compounds due to greater amounts of com¬ 
pound on the leaf surface from 3 applications on the day of inoculation, 
abrasion of the leaf'surface during inoculation, and the presence of a 
spreader-sticker. Although a spreader-sticker may possess detergent 
activity causing solubilization of viral protein (Matthews, 1970), 
significant reductions in local lesion numbers due to the presence of 
spreader-sticker were not observed. Spreader-sticker was not used for 
the application of antiviral compounds onto cowpea plants because it 
caused primary leaves sprayed with many of the compounds to exhibit 
toxic effects possibly resulting from increased compound absorption. 
Besides, the absence of leaf hairs on cowpea plants assured better spray 
coverage by the antiviral compounds than was possible on the primary 
leaves of soybean plants which are covered with leaf hairs. 
Although the differences in local lesion numbers were not statis¬ 
tically significant, local lesion numbers on inoculated soybean plants 
were consistently greater on plants sprayed with 2-thiouracil (all 
treatment regimes) than with any of the other antiviral compounds and 
similar to the lesion numbers of control plants (Table 2). Local le- 
> 
sions on some of the 2-thiouracil-treated primary leaves were so numer¬ 
ous that they coalesced and gave the appearance of large necrotic areas, 
thereby making it difficult to count individual local lesions. Numbers 
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of individual local lesions on 2-thiouracil-treated plants may there¬ 
fore have been even greater than what was actually counted. On the 
other hand, Kuhn (1971) observed significant increases in local lesion 
size when CCMV-inoculated soybean plants were sprayed with 2-thiouracil 
within 24 hours after inoculation. It is possible that some of the 
increases in local lesion size observed by Kuhn (1971) may have been 
due to local lesions becoming so numerous that they could no longer 
be distinguished from each other and were observed as single large 
local lesions. Francki (1962) and Kuhn (1971) observed that 2- 
thiouracil affects virus synthesis and not the host response to infec¬ 
tion. Therefore, the results presented here along with the results of 
others suggest that 2-thiouracil may affect an early stage of the virus 
infection process. 
The early effects of ribavirin on the CCMV infection process may 
be attributed to the inhibition of general RNA synthesis by ribavirin 
through its ability to competitively inhibit an enzyme necessary for 
the synthesis of guanine ribonucleotides in virus-infected cells 
(Browne, 1979; Byhan,£t^., 1978; Goswami, aT ., 1979). A slight 
but non-significant decrease in viral antigen concentration in the pri¬ 
mary leaves of cowpea plants sprayed with ribavirin according to treat¬ 
ment regime E was detected 2 days after inoculation by ELISA (Table 6); 
this again suggests that ribavirin may inhibit an early stage of the 
> 
viral infection process or possibly early viral protein synthesis. The 
inhibitory effects of ribavirin are thought to occur during the early 
synthesis of viral nucleic acid (DeClercq and Luczak, 1975; Simon, ^ aj.. 
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1973) regardless of whether ribavirin is applied before or immediately 
after virus inoculation. 
The early effects of amantadine on the CCMV infection process may 
be attributed to the inhibition by amantadine of viral uncoating (Kato 
and Eggers, 1969) or penetration into the host cell (Grunert, et al., 
1965). The slight increase in viral antigen concentration in the pri¬ 
mary leaves of cowpea plants sprayed with amantadine according to the 
treatment regime E and detected by ELISA at 2 days after inoculation 
(Table 6), if significant, may represent an increase in viral coat 
protein rather than complete virions. However, amantadine has also 
been reported to reduce the synthesis of viral polypeptides (Oxford, 
1979). 
Formycin may inhibit the virus infection process by exhibiting 
an early effect on viral RNA synthesis when applied immediately after 
inoculation (Wawrosch and Sarkar, 1975; Huang, £t jl-, 1966). White 
and Dawson (1979) found that cordycepin, which is an adenosine deriva¬ 
tive like formycin, inhibited in vitro formation of CCMV-RNA by CCMV 
replleases. 
Methisazone was reported to be an effective inhibitor of RNA viruses 
(Woodson and Jolik, 1965; Pearson and Zimmerman, 1969) possibly through 
its effect on the RNA-dependent RNA polymerase responsible for trans¬ 
cription of the viral genome early in the infection process (Tonew, ^ 
> 
aJL., 1974). The significant reduction of local lesion numbers on soy¬ 
bean plants sprayed with methisazone 3 times on the day of inoculation, 
when compared to the local lesion numbers on control plants as well as 
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those on plants receiving the other antiviral treatments, may be parti¬ 
ally due to an elevation of the pH at the leaf surface from repeated 
methisazone application (Table 3). 
Although the reductions in local lesion numbers on plants sprayed 
with methyl benzimidazol-2yl-carbamate prior to or immediately after 
inoculation were not significant (Table 2), the results were in accord¬ 
ance with those of Fraser and Whenham (1978) who found that early appli¬ 
cation of methyl benzimidazol-2yl-carbamate onto tobacco plants (up to 
30 days before inoculation) was most effective for inhibiting TMV infec- 
tivity. It is uncertain whether methyl benzimidazol-2yl-carbamate 
affects early viral RNA synthesis (Fraser and Whenham, 1978) or indi¬ 
rectly affects virus synthesis through an early effect on host RNA syn¬ 
thesis (Tamm and Eggers, 1963). 
With the exceptions of 2-thiouracil (Tables 4 and 5) and ribavirin 
(Table 5), application of the antiviral compounds onto inoculated cowpea 
plants failed to significantly affect the infectivity of CCMV within 10 
days after inoculation. This suggests that later stages of the viral 
infection process occurring within 10 days after inoculation are not 
directly affected by these chemicals. The systemic infection in CCMV- 
inoculated cowpea plants may have been less sensitive to the effects of 
the antiviral compounds than the hypersensitive response of local lesion 
formation on CCMV-inoculated soybean plants. Since the systemic infec- 
> 
tion process in virus-infected plants occurs over a much longer period 
of time than local lesion formation, differences in the infectivity of 
CCMV in systemically infected cowpea plants may be more subtle than the 
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differences in local lesion numbers produced on soybean plants. This 
is because virus replication in cowpea plants may have a chance to re¬ 
cover from the effects of the antiviral compounds within the 10 days 
after inoculation and then proceed at an almost normal rate. Therefore, 
the same effects that were induced by the antiviral compounds early in 
the infection process of soybean plants may also have occurred in inocu¬ 
lated cowpea plants treated with the antiviral compounds. However, 
the effects on systemically infected cowpea plants were not as evident 
either because of the lesser susceptibility of the systemic viral infec¬ 
tion process to the effects of the antiviral compounds or because of 
recovery of viral replication within 10 days after inoculation. 
Similarly, expression of systemic symptoms in CCMV-inoculated cowpea 
plants appeared to be more sensitive to the effects of the antiviral 
compounds than was CCMV infectivity in inoculated cowpea plants since 
many of the antiviral compounds suppressed viral symptoms in inoculated 
cowpea plants while infectious virus was still present. 
2-Thiouracil may inhibit or enhance the CCMV infection process de¬ 
pending on the time of its application. CCMV infectivity in inoculated 
cowpea plants sprayed prior to or immediately after inoculation (treat¬ 
ment regimes B, C, and D) (Table 4) was slightly but nonsignificantly 
reduced. The reduction in infectivity of CCMV in inoculated cowpea 
plants sprayed with 2-thiouracil prior to or immediately after inocula¬ 
tion coincides with a decrease in the development of systemic symptoms 
on plants sprayed with treatment regimes B, C, and D (Fig. 2); this 
again suggests that 2-thiouracil may inhibit an early stage of the virus 
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infection process. In contrast, the infectivity of CCMV was significant¬ 
ly increased when inoculated cowpea plants were sprayed with 2- 
thiouracil after inoculation (treatment regimes E and F) (Tables 4 and 
5) and the increase in CCMV infectivity paralleled an increase in the 
development of systemic symptoms (Fig. 2). Holmes (1955) and Francki 
(1962) observed that 2-thiouracil exhibited a preventative effect 
against TMV multiplication in tobacco when applied before or immediately 
after inoculation. Steele and Black (1967) observed that poliovirus 
was inhibited by 2-thiouracil early in the infection process due to an 
inhibition of viral absorption. In contrast, Dawson and Kuhn (1972) 
observed that when 2-thiouracil was applied daily from inoculation for 
up to 40 days after inoculation infectivity of CCMV from cowpea plants 
increased beginning 4 to 5 days after inoculation. Therefore, 2- 
thiouracil may have two different sites of action: one responsible for 
virus inhibition early in the infection process and another responsible 
for virus enhancement which occurs later in the infection process. Both 
the inhibitory and enhancing effects of 2-thiouracil on virus infectiv¬ 
ity can be counteracted by uracil (Dawson and Kuhn, 1972; Bawden and 
Kassanis, 1954) which suggests that 2-thiouracil probably affects virus 
replication by interfering with the incorporation of uracil into viral 
RNA. 
The slight reductions in the infectivity of CCMV in inoculated 
cowpea plants sprayed with all ribavirin treatment regimes evident 
> 
within 10 days after inoculation (Tables 4 and 5) and the reduction of 
viral antigen from 4 to 8 days after inoculation (Table 6) coincide 
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with an almost complete absence of viral symptoms on ribavirin-treated 
cowpea plants (Fig. 3) and the early inhibitory effects on local le¬ 
sion formation on inoculated soybean plants (Tables 2 and 3). In addi¬ 
tion to the early inhibitory effects of ribavirin on viral RNA synthesis 
ribavirin may also indirectly affect virus synthesis through possible 
effects on the resistance of the host (deFazio, ^ , 1980). Riba-, 
virin may induce increased tolerance or host resistance of cowpea plants 
to CCMV infection since ribavirin-treated plants are almost free of 
viral symptoms although they still contain infectious CCMV after 10 days 
from inoculation (Tables 4, 5, and 6). Since a significant reduction in 
the infectivity of CCMV from trifoliate leaves of cowpea plants sprayed 
with treatment regime E was observed within 10 days after inoculation 
(Table 5), CCMV in younger trifoliate leaves may have been more sensi¬ 
tive to the inhibitory effects of ribavirin regardless of whether riba¬ 
virin affected early viral RNA synthesis or host resistance to viral 
infection. 
Application of amantadine also did not significantly reduce the 
infectivity of CCMV in inoculated cowpea plants within 10 days after 
inoculation. However, the slight reductions in the infectivity of CCMV 
in plants sprayed with treatment regimes A through E (Tables 4 and 5) 
and the slight reduction of viral antigen at 8 days after inoculation 
(Table 6) coincide with an almost complete absence of viral symptoms 
in cowpea plants sprayed with treatment regimes A through E (Fig. 4). 
> 
Treatment regime F which did not begin until 1 day after inoculation 
was not effective in reducing CCMV infectivity (Table 4) which again 
64 
suggests, along with the early inhibitory effects on local lesion forma¬ 
tion on soybean plants (Tables 2 and 3), that amantadine inhibits virus 
infectivity early in the infection process (absorption or uncoating) 
when applied prior to or immediately after inoculation. 
Although formycin, methisazone, and methyl benzimidazol-2yl- 
carbamate failed to significantly reduce the infectivity of CCMV in in¬ 
oculated cowpea plants within 10 days after inoculation (Tables 4 and 5) 
formycin prevented the development of viral symptoms when applied ac¬ 
cording to treatment regimes A through E (Fig. 5) and methisazone pre¬ 
vented the development of viral symptoms when applied according to 
treatment regimes A through F (Fig. 6). These reductions in symptom 
development coincide with the reductions in local lesion numbers on 
inoculated soybean plants (Tables 2 and 3) and may be due to possible 
early effects of formycin and methisazone on viral RNA synthesis. This 
again suggests that symptom development of inoculated cowpea plants 
may be more sensitive to the effects of the antiviral compounds than the 
infectivity of CCMV in the inoculated cowpea plants or that symptom 
development could be affected if the antiviral compound increases host 
resistance to virus infection rather than exhibiting a direct effect on 
the virus. Methyl benzimidazol-2yl-carbamate, in addition to having 
little effect on CCMV infectivity in primary leaves of cowpea plants 
(Table 4), did not affect symptom development on CCMV-inoculated cowpea 
plants (Fig. 7). Since virus in the younger, upper leaves of the plant 
> 
may be more sensitive to the effects of methyl benzimidazol-2yl- 
carbamate (Fraser and Whenham, 1978), it may be necessary to assay the 
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younger trifoliate leaves of inoculated cowpea plants to detect possible 
effects of methyl benzimidazol-2yl-carbamate on CCMV infectivity. 
None of the antiviral compounds significantly reduced CCMV infecti¬ 
vity when compared to the infectivity of CCMV in inoculated control 
plants after 15 or more days from inoculation of sprayed cowpea plants 
suggesting that virus breakdown or stability was not affected by any of 
the antiviral compounds (Tables 5 and 6). The reduced infectivity of 
CCMV in all inoculated cowpea plants at 22 days after inoculation when 
compared to the infectivity of CCMV in inoculated cowpea plants at 10 
and 16 days after inoculation and the extreme variability in infectivity 
of CCMV 22 days after inoculation in all inoculated cowpea plants (Table 
5) may be attributed to the fall in virus concentration frequently ob¬ 
served with increasing age of the infected leaves (Matthews, 1970). 
Therefore, further comparisons of the effects of the antiviral compounds 
on the infectivity of CCMV at 22 days after inoculation may be meaning¬ 
less. However, the reduced infectivity of CCMV observed 22 days after 
inoculation in cowpea plants sprayed with 2-thiouracil treatment regime 
E when compared to the infectivity of CCMV in control plants and plants 
treated with all other antiviral treatments (Table 5) may be due to in¬ 
creased breakdown of CCMV since Dawson and Kuhn (1972) observed an in¬ 
creased breakdown of CCMV in 2-thiouracil-treated cowpea plants begin¬ 
ning 14 days after inoculation. The infectivity of CCMV remained con¬ 
siderably greater in amantadine and some methisazone-treated cowpea 
> 
plants assayed 22 days after inoculation (Table 5) than in control plants 
or in plants treated with the other antiviral compounds. This suggests 
66 
that amantadine and perhaps methisazone may help to prevent virus break¬ 
down and to prolong its infectivity. 
No further reductions in the development of symptoms on CCMV- 
inoculated cowpea plants treated with any of the antiviral compounds 
occurred after the 10th and up to the 42nd day after inoculation. This 
indicates that virus stability was not affected by the antiviral com¬ 
pounds after relatively long periods of time from inoculation. Moreover, 
the young trifoliate leaves of inoculated cowpea plants sprayed with 
2-thiouracil treatment regimes B and D; ribavirin treatment regimes A, 
B, C, and D; amantadine treatment regimes E and F; and formycin treat¬ 
ment regime E, which exhibited suppression of symptoms within 10 days 
after inoculation, showed increased symptom development 42 days after 
inoculation indicating that the antiviral effects are not always perman¬ 
ent. 
The toxicity of 2-thiouracil, formycin, and methisazone to the 
virus-infected host plant (Fig. 2, 5, and 6) may render them useless as 
plant virus chemotherapeutants. It is not likely that methyl 
benzimidazol-2yl-carbamate would be useful as a plant virus chemothera- 
peutant due to its inability to suppress symptom development on the 
virus-infected host plant (Fig. 7). The lack of toxicity of ribavirin 
and the presence of only mild toxicity of amantadine to the virus- 
infected host plants along with the ability of both antiviral compounds 
to suppress viral symptoms (Fig. 3 and 4) suggest that these two chem¬ 
icals may have potential for use as plant virus chemotherapeutants. 
Although the local lesion assay generally results in considerable 
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variability and consistently yields a large standard deviation when lo¬ 
cal lesion numbers are statistically analyzed, it is so far the most 
accurate, if not the only, assay for detecting the infectivity of 
plant viruses. The eight replications per treatment used here is the 
normal number of replications employed in experiments of this type. 
However, due to the extreme variability in the system perhaps a consid¬ 
erably greater number of treatment replications would have resulted in a 
more normal distribution of the local lesion numbers and would have 
lowered the standard deviations among treatment means so that signifi¬ 
cant differences would become apparent (Zar, 1974). For these reasons, 
only general trends in the effects of these antiviral compounds on the 
infectivity of CCMV can be reported. These trends in infectivity are 
also generally supported by visual observations of the reduction in 
symptoms caused by the antiviral compounds. Alternative methods of 
compound application or more frequent or prolonged applications of these 
compounds on the plant might also have made the effects of these anti¬ 
viral compounds on CCMV infectivity more evident. Finally, although 
the virus-host system of CCMV in cowpea and soybean plants provided a 
rapid means for screening the antiviral compounds, it may not have been 
the most suitable system for studying the effectiveness of these chemi¬ 
cals as antiviral agents. It is possible that other viruses with dif¬ 
ferent nucleoprotein composition and replication may be more sensitive 
to these compounds than the isometric, single-stranded RNA virion of 
CCMV. 
CHAPTER VI 
SUMMARY 
Six compounds all previously shown to inhibit certain animal or 
other plant viruses, were sprayed on the primary leaves of cowpea and 
soybean plants to determine their effects on symptom development on the 
virus-infected plant and on the infectivity of the virus, cowpea chloro¬ 
tic mottle virus (CCMV). The compounds sprayed were as follows: 2- 
thiouracil , ribavirin, amantadine, formycin, methisazone, and methyl 
benzimidazol-2yl-carbamate. 
Inoculated cowpea plants sprayed with ribavirin and amantadine 
exhibited almost complete suppression of symptom development, but only 
slight decreases in CCMV infectivity, and little or no toxic effects. 
Inoculated cowpea plants sprayed with 2-thiouracil exhibited somewhat 
increased symptom development and increased CCMV infectivity, along with 
severe phytotoxicity. Inoculated cowpea plants sprayed with formycin 
exhibited a slight reduction in the development of viral symptoms, little 
or no decreases in CCMV infectivity, and severe phytotoxicity. 
Methisazone suppressed symptom development on inoculated cowpea plants 
and caused slight reductions in CCMV infectivity, along with a hormonal- 
like phytotoxic effect on the plants. Methyl benzimidazol-2yl-carbamate 
had no toxic effects on inoculated cowpea plants but symptom expression 
> 
and CCMV infectivity remained comparable to that of the inoculated 
control plants. 
All six antiviral compounds caused some but statistically non- 
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significant reductions in local lesion formation on CCMV-inoculated 
soybean plants. However, when ribavirin, amantadine, formycin, and 
methisazone were sprayed on soybean plants three times on the day of 
inoculation, they all reduced local lesion numbers significantly. 
Quantitative determination of viral antigen by ELISA showed that 
ribavirin and amantadine caused slight, but statistically nonsignifi¬ 
cant reductions in viral antigen in sap from infected cowpea plants 
compared to the inoculated control plants. 
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